| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.03 |